Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ST6GALNAC5 |
| Upstream (Parents) |
|---|
| (<<) ISLR → ST6GALNAC5 |
| (<<) SPOCK1 → ST6GALNAC5 |
| (<<) ADAM12 → ST6GALNAC5 |
| Downstream (Children) |
|---|
| ST6GALNAC5 → PDYN (>>) |
| ST6GALNAC5 → PAX3 (>>) |
| ST6GALNAC5 → CHD2 (>>) |
| ST6GALNAC5 → RPS8P10///RPS8 (>>) |
| ST6GALNAC5 → GALNT10 (>>) |
| ST6GALNAC5 → FGF16 (>>) |
| ST6GALNAC5 → PRM2 (>>) |
| ST6GALNAC5 → RXRG (>>) |
| ST6GALNAC5 → TULP1 (>>) |
| ST6GALNAC5 → TCF25 (>>) |
| ST6GALNAC5 → MED31 (>>) |
| ST6GALNAC5 → MAPK7 (>>) |
| ST6GALNAC5 → RNF144A (>>) |
| ST6GALNAC5 → PIGO (>>) |
| ST6GALNAC5 → MPPE1 (>>) |
| ST6GALNAC5 → TSKS (>>) |
| ST6GALNAC5 → LOC730755///KAP2.1B///KRTAP2-4 (>>) |
